{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:35:05Z","timestamp":1790886905961,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cone contrast threshold testing (CCT) provides quantitative measurements of color and contrast function to reveal changes in vision quality that are not standard endpoints in clinical trials. We utilize CCT to measure visual function in patients with multiple sclerosis (MS), age-related macular degeneration (AMD), epiretinal membrane (ERM), and retinal vein occlusion (RVO).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective data was gathered from 237 patients of the Gavin Herbert Eye Institute. Subjects included 17 patients with MS, 45 patients with AMD, 41 patients with ERM, 11 patients with RVO, and 123 healthy controls. Patients underwent the primary measurement outcome, CCT testing, as well as Sloan visual acuity test and spectral domain optical coherence tomography during normal care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Color and contrast deficits were present in MS patients regardless of history of optic neuritis. AMD with intermediate or worse disease demonstrated reduced CCT scores. All 3 stages of ERM demonstrated cone contrast deficits. Despite restoration of visual acuity, RVO-affected eyes demonstrated poorer CCT performance than unaffected fellow eyes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>CCT demonstrates color and contrast deficits for multiple retinal diseases with differing pathophysiology. Further prospective studies of CCT in other disease states and with larger samples sizes is warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40942-023-00442-3","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T04:09:08Z","timestamp":1675310948000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Quantitative cone contrast threshold testing in patients with differing pathophysiological mechanisms causing retinal diseases"],"prefix":"10.1186","volume":"9","author":[{"given":"Kayla M.","family":"White","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6390-7473","authenticated-orcid":false,"given":"Itamar","family":"Livnat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline R.","family":"Frambach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Doan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urmi V.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Yuh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton M.","family":"Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly A.","family":"Jameson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Cristina","family":"Kenney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitul C.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal J.","family":"Boisvert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wade R.","family":"Crow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew W.","family":"Browne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,2]]},"reference":[{"key":"442_CR1","doi-asserted-by":"crossref","unstructured":"Pointer MR, Attridge GG. The number of discernible colours. Color Research & Application: Endorsed by Inter\u2010Society Color Council, The Colour Group (Great Britain), Canadian Society for Color, Color Science Association of Japan, Dutch Society for the Study of Color, The Swedish Colour Centre Foundation, Colour Society of Australia, Centre Fran\u00e7ais de la Couleur 23.1 (1998): 52\u201354.","DOI":"10.1002\/(SICI)1520-6378(199802)23:1<52::AID-COL8>3.0.CO;2-2"},{"key":"442_CR2","doi-asserted-by":"crossref","unstructured":"Mollon JD, Est\u00e9vez O, Cavonius CR. The two subsystems of colour vision and their roles in wavelength discrimination. In: Vision: coding and efficiency. 1990; p. 119\u2013131.","DOI":"10.1017\/CBO9780511626197.013"},{"issue":"4","key":"442_CR3","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3357\/AMHP.4391.2016","volume":"87","author":"DV Walsh","year":"2016","unstructured":"Walsh DV, Robinson J, Jurek GM, Capo-Aponte JE, Riggs DW, Temme LA. A performance comparison of color vision tests for military screening. Aerosp Med Hum Perform. 2016;87(4):382\u20137.","journal-title":"Aerosp Med Hum Perform"},{"key":"442_CR4","first-page":"311","volume":"107","author":"PK Kaiser","year":"2009","unstructured":"Kaiser PK. Prospective evaluation of visual acuity assessment: a comparison of snellen versus ETDRS charts in clinical practice (An AOS Thesis). Trans Am Ophthalmol Soc. 2009;107:311\u201324.","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"3","key":"442_CR5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1475-1313.2004.00191.x","volume":"24","author":"P Flanagan","year":"2004","unstructured":"Flanagan P, Zele AJ. Chromatic and luminance losses with multiple sclerosis and optic neuritis measured using dynamic random luminance contrast noise. Ophthalmic Physiol Opt. 2004;24(3):225\u201333.","journal-title":"Ophthalmic Physiol Opt"},{"issue":"7","key":"442_CR6","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1517\/17530059.2.7.789","volume":"2","author":"G Hudson","year":"2008","unstructured":"Hudson G, Yu-Wai-Man P, Chinnery PF. Leber hereditary optic neuropathy. Expert Opin Med Diagn. 2008;2(7):789\u201399.","journal-title":"Expert Opin Med Diagn"},{"issue":"3","key":"442_CR7","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1017\/S0952523808080437","volume":"25","author":"ALDA Moura","year":"2008","unstructured":"Moura ALDA, Teixeira RAA, Oiwa NN, Costa MF, Feitosa-Santana C, Callegaro D, Hamer RD, Ventura DF. Chromatic discrimination losses in multiple sclerosis patients with and without optic neuritis using the Cambridge Colour Test. Vis Neurosci. 2008;25(3):463\u20138.","journal-title":"Vis Neurosci"},{"issue":"1","key":"442_CR8","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.joco.2018.11.003","volume":"31","author":"MT Rajabi","year":"2019","unstructured":"Rajabi MT, Ojani M, RiaziEsfahani H, Tabatabaei SZ, Rajabi MB, Hosseini SS. Correlation of peripapillary nerve fiber layer thickness with visual outcomes after decompression surgery in subclinical and clinical thyroid-related compressive optic neuropathy. J Curr Ophthalmol. 2019;31(1):86\u201391.","journal-title":"J Curr Ophthalmol"},{"issue":"1","key":"442_CR9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.oftal.2018.08.006","volume":"94","author":"A FanloZarazaga","year":"2019","unstructured":"FanloZarazaga A, Gutierrez Vasquez J, Pueyo RV. Review of the main colour vision clinical assessment tests. Arch Soc Esp Oftalmol. 2019;94(1):25\u201332.","journal-title":"Arch Soc Esp Oftalmol"},{"issue":"2","key":"442_CR10","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/j.1475-1313.1989.tb00836.x","volume":"9","author":"J Birch","year":"1989","unstructured":"Birch J. Use of the Farnsworth-Munsell 100-Hue test in the examination of congenital colour vision defects. Ophthalmic Physiol Opt. 1989;9(2):156\u201362.","journal-title":"Ophthalmic Physiol Opt"},{"issue":"4","key":"442_CR11","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s10792-013-9865-9","volume":"34","author":"S Ghose","year":"2014","unstructured":"Ghose S, Parmar T, Dada T, Vanathi M, Sharma S. A new computer-based Farnsworth Munsell 100-hue test for evaluation of color vision. Int Ophthalmol. 2014;34(4):747\u201351.","journal-title":"Int Ophthalmol"},{"issue":"5","key":"442_CR12","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1167\/iovs.14-16094","volume":"56","author":"MB Cranwell","year":"2015","unstructured":"Cranwell MB, Pearce B, Loveridge C, Hurlbert AC. Performance on the Farnsworth-Munsell 100-Hue test is significantly related to nonverbal IQ. Invest Ophthalmol Vis Sci. 2015;56(5):3171\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"442_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1167\/13.7.3","volume":"13","author":"N Prins","year":"2013","unstructured":"Prins N. The psi-marginal adaptive method: how to give nuisance parameters the attention they deserve (no more, no less). J Vis. 2013;13(7):3.","journal-title":"J Vis"},{"issue":"2","key":"442_CR14","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1167\/iovs.10-6283","volume":"52","author":"J Rabin","year":"2011","unstructured":"Rabin J, Gooch J, Ivan D. Rapid quantification of color vision: the cone contrast test. Invest Ophthalmol Vis Sci. 2011;52(2):816\u201320.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"442_CR15","first-page":"46","volume":"19","author":"U Mehta","year":"2020","unstructured":"Mehta U, Diep A, Nguyen K, Le B, Yuh C, Frambach C, Doan J, Wei A, Palma AM, Farid M, Garg S. Quantifying color vision changes associated with cataracts using cone contrast thresholds. Tran Vis Sci Tech. 2020;19:46.","journal-title":"Tran Vis Sci Tech."},{"issue":"11","key":"442_CR16","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1007\/s00415-015-7876-3","volume":"262","author":"EJ Lampert","year":"2015","unstructured":"Lampert EJ, Andorra M, Torres-Torres R, Ortiz-P\u00e9rez S, Llufriu S, Sep\u00falveda M, Sola N, Saiz A, S\u00e1nchez-Dalmau B, Villoslada P, Mart\u00ednez-Lapiscina EH. Color vision impairment in multiple sclerosis points to retinal ganglion cell damage. J Neurol. 2015;262(11):2491\u20137.","journal-title":"J Neurol"},{"issue":"1","key":"442_CR17","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/WNO.0000000000000486","volume":"37","author":"H Felgueiras","year":"2017","unstructured":"Felgueiras H, Parra J, Cruz S, Pereira P, Santos AF, Rua A, Meira D, Fonseca P, Pedrosa C, Cardoso JN, Almeida C. Dyschromatopsia in multiple sclerosis patients: a marker of subclinical involvement?: Response. J Neuroophthalmol. 2017;37(1):108\u20139.","journal-title":"J Neuroophthalmol"},{"issue":"9","key":"442_CR18","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1177\/1352458513517591","volume":"20","author":"EH Mart\u00ednez-Lapiscina","year":"2014","unstructured":"Mart\u00ednez-Lapiscina EH, Ortiz-P\u00e9rez S, Fraga-Pumar E, Mart\u00ednez-Heras E, Gabilondo I, Llufriu S, Bullich S, Figueras M, Saiz A, S\u00e1nchez-Dalmau B, Villoslada P. Colour vision impairment is associated with disease severity in multiple sclerosis. Mult Scler. 2014;20(9):1207\u201316.","journal-title":"Mult Scler"},{"key":"442_CR19","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.2147\/CIA.S143508","volume":"12","author":"WM Al-Zamil","year":"2017","unstructured":"Al-Zamil WM, Yassin SA. Recent developments in age-related macular degeneration: a review. Clin Interv Aging. 2017;12:1313\u201330.","journal-title":"Clin Interv Aging"},{"issue":"2","key":"442_CR20","first-page":"74","volume":"59","author":"A Gheorghe","year":"2015","unstructured":"Gheorghe A, Mahdi L, Musat O. Age-related macular degeneration. Rom J Ophthalmol. 2015;59(2):74\u20137.","journal-title":"Rom J Ophthalmol"},{"key":"442_CR21","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ajo.2018.02.012","volume":"189","author":"KJ Cocce","year":"2018","unstructured":"Cocce KJ, Stinnett SS, Luhmann UF, Vajzovic L, Horne A, Schuman SG, Toth CA, Cousins SW, Lad EM. Visual function metrics in early and intermediate dry age-related macular degeneration for use as clinical trial endpoints. Am J Ophthalmol. 2018;189:127\u201338.","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"442_CR22","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1097\/IAE.0000000000000349","volume":"34","author":"SC Bu","year":"2014","unstructured":"Bu SC, Kuijer R, Li XR, Hooymans JM, Los LI. Idiopathic epiretinal membrane. Retina. 2014;34(12):2317\u201335.","journal-title":"Retina"},{"issue":"2","key":"442_CR23","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1001\/jamaophthalmol.2013.686","volume":"131","author":"K Watanabe","year":"2013","unstructured":"Watanabe K, Tsunoda K, Mizuno Y, Akiyama K, Noda T. Outer retinal morphology and visual function in patients with idiopathic epiretinal membrane. JAMA Ophthalmol. 2013;131(2):172\u20137.","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"442_CR24","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s00417-011-1848-9","volume":"250","author":"HC Koo","year":"2012","unstructured":"Koo HC, Rhim WI, Lee EK. Morphologic and functional association of retinal layers beneath the epiretinal membrane with spectral-domain optical coherence tomography in eyes without photoreceptor abnormality. Graefes Arch Clin Exp Ophthalmol. 2012;250(4):491\u20138.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"10","key":"442_CR25","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1016\/j.ophtha.2012.05.017","volume":"119","author":"R Varma","year":"2012","unstructured":"Varma R, Bressler NM, Su\u00f1er I, Lee P, Dolan CM, Ward J, Colman S, Rubio RG. Improved vision-related function after ranibizumab for macular edema after retinal vein occlusion: results from the BRAVO and CRUISE trials. Ophthalmology. 2012;119(10):2108\u201318.","journal-title":"Ophthalmology"},{"issue":"3","key":"442_CR26","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.ajo.2012.09.026","volume":"155","author":"DM Brown","year":"2013","unstructured":"Brown DM, Heier JS, Clark WL, Boyer DS, Vitti R, Berliner AJ, Zeitz O, Sandbrink R, Zhu X, Haller JA. Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS study. Am J Ophthalmol. 2013;155(3):429-437e427.","journal-title":"Am J Ophthalmol."},{"issue":"9","key":"442_CR27","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1001\/archophthalmol.2009.234","volume":"127","author":"MS Ip","year":"2009","unstructured":"Ip MS, Scott IU, VanVeldhuisen PC, Oden NL, Blodi BA, Fisher M, Chan CK, Gonzalez VH, Singerman LJ, Tolentino M. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. Arch Ophthalmol. 2009;127(9):1101\u201314.","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"442_CR28","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1001\/archophthalmol.2009.233","volume":"127","author":"IU Scott","year":"2009","unstructured":"Scott IU, Ip MS, VanVeldhuisen PC, Oden NL, Blodi BA, Fisher M, Chan CK, Gonzalez VH, Singerman LJ, Tolentino M. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report. Arch Ophthalmol. 2009;127(9):1115\u201328.","journal-title":"Arch Ophthalmol"},{"issue":"11","key":"442_CR29","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1001\/archopht.123.11.1570","volume":"123","author":"FL Ferris","year":"2005","unstructured":"Ferris FL, Davis MD, Clemons TE, Lee LY, Chew EY, Lindblad AS, Milton RC, Bressler SB, Klein R. A simplified severity scale for age-related macular degeneration: AREDS Report. Arch Ophthalmol. 2005;123(11):1570\u20134.","journal-title":"Arch Ophthalmol."},{"issue":"9","key":"442_CR30","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1016\/j.ophtha.2016.05.043","volume":"123","author":"G Liew","year":"2016","unstructured":"Liew G, Joachim N, Mitchell P, Burlutsky G, Wang JJ. Validating the AREDS simplified severity scale of age-related macular degeneration with 5- and 10-year incident data in a population-based sample. Ophthalmology. 2016;123(9):1874\u20138.","journal-title":"Ophthalmology"},{"key":"442_CR31","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ajo.2016.12.006","volume":"175","author":"A Govetto","year":"2017","unstructured":"Govetto A, Lalane RA 3rd, Sarraf D, Figueroa MS, Hubschman JP. Insights into epiretinal membranes: presence of ectopic inner foveal layers and a new optical coherence tomography staging scheme. Am J Ophthalmol. 2017;175:99\u2013113.","journal-title":"Am J Ophthalmol"},{"key":"442_CR32","unstructured":"R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. http:\/\/www.R-project.org\/. In:2019."},{"issue":"6","key":"442_CR33","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.ajo.2010.01.011","volume":"149","author":"Y Almog","year":"2010","unstructured":"Almog Y, Nemet A. The correlation between visual acuity and color vision as an indicator of the cause of visual loss. Am J Ophthalmol. 2010;149(6):1000\u20134.","journal-title":"Am J Ophthalmol"},{"key":"442_CR34","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40662-016-0063-5","volume":"3","author":"KL Pennington","year":"2016","unstructured":"Pennington KL, DeAngelis MM. Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors. Eye Vis (Lond). 2016;3:34.","journal-title":"Eye Vis (Lond)"},{"issue":"9","key":"442_CR35","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1097\/IAE.0b013e3181ee5ce8","volume":"30","author":"RF Spaide","year":"2010","unstructured":"Spaide RF, Curcio CA. Drusen characterization with multimodal imaging. Retina. 2010;30(9):1441\u201354.","journal-title":"Retina"},{"key":"442_CR36","unstructured":"Apellis Pharmaceuticals I. Study of of APL-2 Therapy in Patients Geographic Atrophy (FILLY). In. (Clinicaltrials.gov Identifier NCT0250332)2015."},{"issue":"6","key":"442_CR37","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1001\/jamaophthalmol.2018.1544","volume":"136","author":"FG Holz","year":"2018","unstructured":"Holz FG, Sadda SR, Busbee B, Chew EY, Mitchell P, Tufail A, Brittain C, Ferrara D, Gray S, Honigberg L, Martin J. Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: chroma and spectri phase 3 randomized clinical trials. JAMA Ophthalmol. 2018;136(6):666\u201377.","journal-title":"JAMA Ophthalmol"},{"issue":"7","key":"442_CR38","first-page":"317","volume":"63","author":"VH Oza","year":"2022","unstructured":"Oza VH, Kurzlechner L, Nordstrom C, Luhmann UF, Stinnett S, Lad EM. Cone contrast testing as an early functional biomarker of age-related macular degeneration. Invest Ophthalmol Vis Sci. 2022;63(7):317-F0148.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"442_CR39","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1136\/bjo.86.8.902","volume":"86","author":"A Gandorfer","year":"2002","unstructured":"Gandorfer A, Rohleder M, Kampik A. Epiretinal pathology of vitreomacular traction syndrome. Br J Ophthalmol. 2002;86(8):902\u20139.","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"442_CR40","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.ophtha.2011.08.026","volume":"119","author":"K Tsunoda","year":"2012","unstructured":"Tsunoda K, Watanabe K, Akiyama K, Usui T, Noda T. Highly reflective foveal region in optical coherence tomography in eyes with vitreomacular traction or epiretinal membrane. Ophthalmology. 2012;119(3):581\u20137.","journal-title":"Ophthalmology"},{"issue":"12","key":"442_CR41","doi-asserted-by":"publisher","first-page":"7302","DOI":"10.1167\/iovs.13-12702","volume":"54","author":"Y Itoh","year":"2013","unstructured":"Itoh Y, Inoue M, Rii T, Hirota K, Hirakata A. Correlation between foveal cone outer segment tips line and visual recovery after epiretinal membrane surgery. Invest Ophthalmol Vis Sci. 2013;54(12):7302\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"442_CR42","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.jcjo.2014.06.007","volume":"49","author":"T Rii","year":"2014","unstructured":"Rii T, Itoh Y, Inoue M, Hirota K, Hirakata A. Outer retinal morphological changes and visual function after removal of epiretinal membrane. Can J Ophthalmol. 2014;49(5):436\u201342.","journal-title":"Can J Ophthalmol"},{"issue":"3","key":"442_CR43","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1097\/IAE.0000000000000843","volume":"36","author":"M Ho","year":"2016","unstructured":"Ho M, Liu DT, Lam DS, Jonas JB. Retinal vein occlusions, from basics to the latest treatment. Retina. 2016;36(3):432\u201348.","journal-title":"Retina"},{"issue":"10","key":"442_CR44","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1007\/s00417-021-05171-7","volume":"259","author":"R Matsumoto","year":"2021","unstructured":"Matsumoto R, Saishin Y, Ohji M. Evaluation of acquired color vision deficiency in retinal vein occlusion using the Rabin cone contrast test. Graefe\u2019s Arch Clin Exp Ophthalmol. 2021;259(10):2961\u20136.","journal-title":"Graefe's Arch Clin Exp Ophthalmol"},{"issue":"10","key":"442_CR45","doi-asserted-by":"publisher","first-page":"6686","DOI":"10.1167\/iovs.14-14079","volume":"55","author":"Y Niwa","year":"2014","unstructured":"Niwa Y, Muraki S, Naito F, Minamikawa T, Ohji M. Evaluation of acquired color vision deficiency in glaucoma using the Rabin cone contrast test. Inv Ophthalmol Vis Sci. 2014;55(10):6686\u201390.","journal-title":"Inv Ophthalmol Vis Sci"},{"issue":"7","key":"442_CR46","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s00417-010-1326-9","volume":"248","author":"XL Wang","year":"2010","unstructured":"Wang XL, Yu T, Xia DEZ, Zhang JS, Yan QIC, Luo YAH. Measurement of retinal nerve fiber layer thickness in optic atrophy eyes of patients with optic neuritis using optical coherence tomography. Graefe\u2019s Arch Clin Exp Ophthalmol. 2010;248(7):1013\u20138.","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"issue":"8","key":"442_CR47","doi-asserted-by":"publisher","first-page":"675","DOI":"10.3389\/fneur.2017.00675","volume":"13","author":"U Birkeldh","year":"2017","unstructured":"Birkeldh U, Manouchehrinia A, Hietala MA, Hillert J, Olsson T, Piehl F, Kockum IS, Brundin L, Zahavi O, Wahlberg-Ramsay M, Brautaset R, Nilsson M. The temporal retinal nerve fiber layer thickness is the most important optical coherence tomography estimate in multiple sclerosis. Front Neurol. 2017;13(8):675. https:\/\/doi.org\/10.3389\/fneur.2017.00675. (PMID:29326643; PMCID:PMC5733353).","journal-title":"Front Neurol"},{"issue":"6","key":"442_CR48","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/j.ophtha.2010.02.024","volume":"117","author":"F Bertuzzi","year":"2010","unstructured":"Bertuzzi F, Suzani M, Tagliabue E, Cavaletti G, Angeli R, Balgera R, Rulli E, Ferrarese C, Miglior S. Diagnostic validity of optic disc and retinal nerve fiber layer evaluations in detecting structural changes after optic neuritis. Ophthalmology. 2010;117(6):1256-1264.e1. https:\/\/doi.org\/10.1016\/j.ophtha.2010.02.024. (Epub 2010 Apr 9 PMID: 20381872).","journal-title":"Ophthalmology"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-023-00442-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-023-00442-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-023-00442-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T07:10:05Z","timestamp":1675494605000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalretinavitreous.biomedcentral.com\/articles\/10.1186\/s40942-023-00442-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,2]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["442"],"URL":"https:\/\/doi.org\/10.1186\/s40942-023-00442-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.11.10.20228619","asserted-by":"object"}]},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,2]]},"assertion":[{"value":"18 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional Review Board (IRB)\/Ethics Committee approval was obtained. The study was conducted in accordance with the Declaration of Helsinki. The collection and evaluation of all protected patient health information was performed in a Health Insurance Portability and Accountability Act (HIPAA)-compliant manner.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"The authors declare that there is no conflict of interests with respect to the research, authorship, and\/or publication of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}